Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Exploring the history of generic medicines

Find out how generic medicines came about and examine the economics and politics of generic substitutions.

‘Generic: the unbranding of modern medicine’ by Jeremy A Greene

The dispensing of generic drugs is, in all probability, a daily occurrence for most community pharmacists and hospital pharmacists in the UK. These medicines, less expensive than their branded counterparts, offer considerable savings for a cost-constrained NHS. However, because the colours, shapes and ingredients can often vary for the “same” medicines, it is clear that they are not identical.

Pharmacists and patients alike rely on regulatory authorities to ensure that generic medicines are the same in all the ways that matter. Physician and historian Jeremy Greene examines the question of “sameness” for generic drugs and chronicles the history of the generic drug industry in the United States. Greene explores some of the scientific considerations that have addressed the issue of generic equivalence over the years. The reader is introduced to the pharmacological, physiological and pharmaceutical aspects of generic equivalence, and Greene describes the birth of a new field of study, biopharmaceutics, in the 1950s.

Much of the book, however, is turned over to discussion of the economics and politics of generic substitutions, which, as Greene explains, has proven to be a contentious issue over the past 70 years. The book is primarily focused on the US healthcare system, providing glimpses into evolution of the US Food and Drug Administration and the role of the US senate and the pharmaceutical lobby in healthcare decisions. Greene also addresses the role of the patient as a “consumer”.

It provides a real insight into the history of the US pharmaceutical industry during the 20th century and describes how blockbuster drugs, generics, counterfeit medicines, and “me-too” drugs (a drug that is structurally similar to already known drugs, with only minor differences) have all shaped the model of drug development we have today. Moreover, the book gives a glimpse into the cultural history of consumerism in the United States by examining how generic drugs were perceived by a paying public and how marketing was used to influence this.

The text is very much a historical account and will be of most interest to pharmacists with an enthusiasm for the history of pharmacy, rather than those looking for a detailed scientific examination of generic products.

Citation: The Pharmaceutical Journal URI: 20066951

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Essentials of Economic Evaluation in Healthcare

    Essentials of Economic Evaluation in Healthcare

    An introduction to economic evaluation specific to healthcare, for those with little or no knowledge of economics. Covers cost effectiveness, cost utility and cost benefit analysis.

    £33.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.